טוען...
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
BACKGROUND: Interventions to protect young infants against respiratory syncytial virus (RSV) are in advanced phases of development and are expected to be available in the foreseeable future. Gavi, the Vaccine Alliance, included maternal vaccines and infant monoclonal antibodies for RSV as part of th...
שמור ב:
| הוצא לאור ב: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Science
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342012/ https://ncbi.nlm.nih.gov/pubmed/32586761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.036 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|